<h3>Activity 1 - Data Element Naming</h3>
<h4>Data Set Exemple</h4>
<p>You are provided with the following summary data set to collect information on HIV, malaria and TB. We will use this example to properly name, create and group data elements. Please see the following sections.</p>
<table>
<tbody>
<tr>
<td>Data Element</td>
<td>Value</td>
</tr>
<tr>
<td>Number of female sex workers reached with HIV prevention programs (Outreach)</td>
<td></td>
</tr>
<tr>
<td>Number of PLHIV Attended</td>
<td></td>
</tr>
<tr>
<td>Number of HIV positive TB patients who are already on ART or started on ART during TB treatment</td>
<td></td>
</tr>
<tr>
<td>TB07.10 Number of patients with positive bacteriological results out of diagnosis</td>
<td></td>
</tr>
<tr>
<td>TB07.19 Number of patients examined for follow-up</td>
<td></td>
</tr>
<tr>
<td>MAL02.01 Malaria Slide (Tested)</td>
<td></td>
</tr>
</tbody>
</table>
<h4>Instructions - Data Element Naming</h4>
<p>Fill in the table below (the 'Name in DHIS 2' column), assigning the data element a name you think is suitable for use in a database such as DHIS 2. You will later be asked to create these in DHIS 2.</p>
<table>
<tbody>
<tr>
<td>Associated Program/Data Set</td>
<td>Name on Form</td>
<td>Name in DHIS2</td>
</tr>
<tr>
<td>HIV<span style="font-size: 7.2pt; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; text-decoration: none; vertical-align: super; white-space: pre-wrap;">1 </span>Program Progress Report</td>
<td>Number of female sex workers reached with HIV prevention programs (Outreach)</td>
<td></td>
</tr>
<tr>
<td>PLHIV<span style="font-size: 7.2pt; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; text-decoration: none; vertical-align: super; white-space: pre-wrap;">2</span> Network Activities</td>
<td>Number of PLHIV Attended</td>
<td></td>
</tr>
<tr style="height: 0pt;">
<td>ART<span style="font-size: 7.2pt; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; text-decoration: none; vertical-align: super; white-space: pre-wrap;">3</span></td>
<td>Number of HIV positive TB patients who are already on ART or started on ART during TB treatment</td>
<td></td>
</tr>
<tr>
<td>TB<span style="font-size: 7.2pt; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; text-decoration: none; vertical-align: super; white-space: pre-wrap;">4</span> 07</td>
<td>TB07.10 Number of patients with positive bacteriological results out of diagnosis</td>
<td></td>
</tr>
<tr style="height: 0pt;">
<td>TB 07</td>
<td>TB07.19 Number of patients examined for follow-up</td>
<td></td>
</tr>
<tr>
<td>Malaria Monthly Report</td>
<td>MAL02.01 Malaria Slide (Tested)</td>
<td></td>
</tr>
</tbody>
</table>
<ol>
<li>Human immunodeficiency virus</li>
<li>People living with HIV</li>
<li>Anti-retro-viral therapy</li>
<li>Tuberculosis</li>
</ol>